Blog


Monday, September 30th 2024

Barriers and enablers of active surveillance for prostate cancer – a qualitive study of clinicians

Pattenden TA, Thangasamy IA, Ong WL, Samaranayke D, Morton A, Murphy DG, Evans S, Millar J, Chalasani V, Rashid P, Winter M, Vela I, Pryor D, Mark S, Loeb S, Lawrentschuk N, Pritchard E.  “Barriers and enablers of active surveillance for prostate cancer – a qualitive study of clinicians.” BJU Int. 2023 Sep 11. Link:… Read More


Comment
Monday, September 30th 2024

Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation

Leapman MS, Wang R, Loeb S, Seibert TM, Gaylis FD, Lowentritt B, Brown GA, Chen R, Lin D, Witte J, Cooperberg MR, Catalona WJ, Gross CP, Ma X.  “Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.” Journal of Urology. 2023 Apr;209(4):710-718. Link: https://pubmed.ncbi.nlm.nih.gov/36753746/


Comment
Monday, September 30th 2024

Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer-A Report of a Movember International Consensus Meeting

Moore CM, King LE, Withington J, Amin MB, Andrews M, Briers E, Chen RC, Chinegwundoh FI, Cooperberg MR, Crowe J, Finelli A, Fitch MI, Frydenberg M, Giganti F, Haider MA, Freeman J, Gallo J, Gibbs S, Henry A, James N, Kinsella N, Lam TBL, Lichty M, Loeb S, Mahal BA, Mastris K, Mitra AV, Merriel… Read More


Comment
Monday, September 30th 2024

A vision for closing the evidence-practice gap in the management of low-grade prostate cancer

Leapman MS, Loeb S, Cooperberg MR, Catalona WJ, Gaylis FD.  “A vision for closing the evidence-practice gap in the management of low-grade prostate cancer.” JNCI Cancer Spectrum. 2023 Mar 1;7(2):pkad028. Link: https://pubmed.ncbi.nlm.nih.gov/37101361/


Comment
Monday, September 30th 2024

Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression

Baboudjian M, Breda A, Rajwa P, Gallioli A, Gondran-Tellier B, Sanguedolce F, Verri P, Diana P, Territo A, Bastide C, Spratt DE, Loeb S, Tosoian JJ, Leapman MS, Palou J, Ploussard G.  “Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression.” Eur Urol Oncol. 2022 Aug 4:S2588-9311(22)00135-3. PMID: 35934625. Link: https://pubmed.ncbi.nlm.nih.gov/35934625/


Comment
Monday, September 30th 2024

Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care

Gaylis FD, Cooperberg MR, Loeb S, Chen RC, Seibert TM, Cohen E, Dato P, Emeka AA, Prime R, Romo S, Catalona WJ.  “Conservative Management of Low-Risk Prostate Cancer: A Path to Value-Based Care.” Urology Practice. 2022 May;9(3):195-197. Link: https://pubmed.ncbi.nlm.nih.gov/37145554/


Comment
Monday, September 30th 2024

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer

Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC.  “Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.” Eur Urol Open Sci. 2022… Read More


Comment
Monday, September 30th 2024

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz… Read More


Comment
Monday, September 30th 2024

Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study

Lowenstein LM, Choi NJ, Hoffman KE, Volk RJ, Loeb S.  “Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study.” BMJ Open. 2021 Nov 12;11(11):e048347. PMID: 34772748. Link: https://pubmed.ncbi.nlm.nih.gov/34772748/


Comment
Monday, September 30th 2024

Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness

Kang SK, Mali RD, Prabhu V, Ferket BS, Loeb S.  “Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.” Radiology. 2021 Sept;300(3):594-604. PMID: 34254851. Link: https://pubmed.ncbi.nlm.nih.gov/34254851/


Comment
Monday, September 30th 2024

Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy

Leapman MS, Thiel CL, Gordon IO, Nolte AC, Perecman A, Loeb S, Overcash M, Sherman JD. “Environmental Impact of Prostate Magnetic Resonance Imaging and Transrectal Ultrasound Guided Prostate Biopsy.” Eur Urol. 2023 Jan 10:S0302-2838(22)02857-3. Link: https://pubmed.ncbi.nlm.nih.gov/36635108/


Comment
Monday, September 30th 2024

Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer

Sundaresan VM, Wang R, Long JB, Sprenkle PC, Seibert TM, Loeb S, Cooperberg MR, Catalona WJ, Ma X, Gross CP, Leapman MS. “Associations Between Prostate Magnetic Resonance Imaging, Genomic Testing, and Treatment for Localized Prostate Cancer.” Urology Practice. 2024 epub Jul 16. PMID: 39196719. Link: https://pubmed.ncbi.nlm.nih.gov/39196719/


Comment
Monday, September 30th 2024

Single-cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile

Adorno Febles VR, Hao Y, Ahsan A, Wu J, Qian Y, Zhong H, Loeb S, Makarov DV, Lepor H, Wysock J, Taneja SS, Huang WC, Becker DJ, Balar AV, Melamed J, Deng FM, Ren Q, Kufe D, Wong KK, Adeegbe DO, Deng J, Wise DR. “Single-cell analysis of localized prostate cancer patients links high Gleason… Read More


Comment
Monday, September 30th 2024

Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer

Leapman MS, Sutherland R, Gross CP, Ma X, Seibert TM, Cooperberg MR, Catalona WJ, Loeb S, Schulman-Green D. “Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer.” BJUI Compass. 2023 Aug 15;5(1):142-149 Link: https://pubmed.ncbi.nlm.nih.gov/38179031/


Comment
Monday, September 30th 2024

Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer

Press BH, Jones T, Olawoyin O, Lokeshwar SD, Rahman SN, Khajir G, Lin DW, Cooperberg MR, Loeb S, Darst BF, Zheng Y, Chen RC, Witte JS, Seibert TM, Catalona WJ, Leapman MS, Sprenkle PC. “Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer.” Eur Urol Open Sci. 2022… Read More


Comment
Saturday, September 28th 2024

Shared decision-making before prostate cancer screening decisions

Pekala KR, Shill DK, Austria M, Langford AT, Loeb S, Carlsson SV. “Shared decision-making before prostate cancer screening decisions” Nature Reviews Urology. 2024; 21: 329 Link: https://pubmed.ncbi.nlm.nih.gov/38168921/


Comment
Saturday, September 28th 2024

Accuracy of prostate cancer screening recommendations for high-risk populations on YouTube and TikTok

Abramson M, Feiertag N, Javidi D, Babar M, Loeb S, Watts K “Accuracy of prostate cancer screening recommendations for high-risk populations on YouTube and TikTok” BJUI Compass. 2022 Nov 8;4(2):206-213 Link: https://pubmed.ncbi.nlm.nih.gov/36816146/


Comment
Saturday, September 28th 2024

Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing

Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana… Read More


Comment
Saturday, September 28th 2024

BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review

Cheng HH, Shevach JW, Castro E, Couch FJ, Domchek SM, Eeles RA, Giri VN, Hall MJ, King MC, Lin DW, Loeb S, Morgan TM, Offit K, Pritchard CC, Schaeffer EM, Szymaniak BM, Vassy JL, Katona BW, Maxwell KN. “BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients: A Review” JAMA Oncology. 2024 Jul… Read More


Comment
Saturday, September 28th 2024

Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board

Loeb S, Cheng HH, Paller CJ, Weg E, Johnson J, Gross L, Keith SW, Russo J, Hathaway F, Rivera A, Giri VN. “Addressing gaps in healthcare provider knowledge regarding germline testing for prostate cancer through development and testing of a virtual genetics board” Prostate Cancer Prostatic Disease. 2024 Jan 3 epub. Link: https://pubmed.ncbi.nlm.nih.gov/38172199/


Comment
Saturday, September 28th 2024

Attitudes, Perceptions, and Use of Cancer-based Genetic Testing Among Healthy U.S. Adults and Those With Prostate or Breast/Ovarian Cancer

Thakker S, Loeb S, Giri VN, Bjurlin MA, Matulewicz RS. “Attitudes, Perceptions, and Use of Cancer-based Genetic Testing Among Healthy U.S. Adults and Those With Prostate or Breast/Ovarian Cancer” Urology Practice. 2023 Jan;10(1):26-32. Epub 2022 Sep 27 Link: https://pubmed.ncbi.nlm.nih.gov/37103438/


Comment
Saturday, September 28th 2024

Usefulness of Podcasts to Provide Public Education on Prostate Cancer Genetics

Loeb S, Sanchez Nolasco T, Siu K, Byrne N, Giri VN. “Usefulness of Podcasts to Provide Public Education on Prostate Cancer Genetics” Prostate Cancer Prostatic Disease 2023; 26: 772 Link: https://pubmed.ncbi.nlm.nih.gov/36681741/


Comment
Saturday, September 28th 2024

Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention

Seibert TM, Garraway IP, Plym A, Mahal BA, Giri V, Jacobs MF, Cheng HH, Loeb S, Helfand BT, Eeles RA, Morgan TM. “Genetic Risk Prediction for Prostate Cancer: Implications for Early Detection and Prevention” Eur Urol. 2023 Jan 4:S0302-2838(22)02870-6 Link: https://pubmed.ncbi.nlm.nih.gov/36609003/


Comment
Saturday, September 28th 2024

Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing

Loeb S, Cheng HH, Leader A, Gross L, Nolasco TS, Byrne N, Wise DR, Hollifield L, Brown LH, Slater E, Pieczonka C, Gomella LG, Kelly WK, Trabulsi EJ, Handley N, Lallas CD, Chandrasekar T, Mille P, Mann M, Mark JR, Brown G, Chopra S, Wasserman J, Phillips J, Somers P, Giri VN. “Technology-enhanced AcceleRation of… Read More


Comment
Saturday, September 28th 2024

Genetic Factors Associated with Prostate Cancer Conversion from Active Surveillance to Treatment

Jiang Y, Meyers TJ, Emeka AA, Cooley LF, Cooper PR, Lancki N, Helenowski I, Kachuri L, Lin DW, Stanford JL, Newcomb LF, Kolb S, Finelli A, Fleshner NE, Komisarenko M, Eastham JA, Ehdaie B, Benfante N, Logothetis CJ, Gregg JR, Perez CA, Garza S, Kim J, Marks LS, Delfin M, Barsa D, Vesprini D, Klotz… Read More


Comment
Saturday, September 28th 2024

Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice

Giri VN, Walker A, Gross L, Trabulsi EJ, Lallas CD, Kelly WK, Gomella LG, Fischer C, Loeb S “Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice” Clinical Genitourinary Cancer. 2021 Nov 27:S1558-7673(21)00220-2. PMID: 35012874 Link: https://pubmed.ncbi.nlm.nih.gov/35012874/


Comment
Saturday, September 28th 2024

Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis

Loeb S, Massey P, Leader AE, Thakker S, Falge E, Taneja S, Byrne N, Rose M, Joy M, Walter D, Katz MS, Wong RL, Selvan P, Keith SW, Giri VN. “Gaps in Public Awareness About BRCA and Genetic Testing in Prostate Cancer: Social Media Landscape Analysis” JMIR Cancer. 2021 Sep 20;7(3):e27063. PMID: 34542414 Link: https://pubmed.ncbi.nlm.nih.gov/34542414/


Comment
Saturday, September 28th 2024

TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing

Loeb S, Keith SW, Cheng HH, Leader AE, Gross L, Sanchez Nolasco T, Byrne N, Hartman R, Brown LH, Pieczonka CM, Gomella LG, Kelly WK, Lallas CD, Handley N, Mille PJ, Mark JR, Brown GA, Chopra S, McClellan A, Wise DR, Hollifield L, Giri VN. “TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic… Read More


Comment
Saturday, September 28th 2024

Barriers and facilitators of germline genetic evaluation for prostate cancer

Loeb S, Li R, Sanchez Nolasco T, Byrne N, Cheng HH, Becker D, Leader AE, Giri VN. “Barriers and facilitators of germline genetic evaluation for prostate cancer” 2021 May 31. PMID: 3405723. Link: https://pubmed.ncbi.nlm.nih.gov/34057231/ Germline genetic testing is currently underutilized in prostate cancer management. In this qualitative study, we identified numerous barriers to genetic evaluation… Read More


Comment
Saturday, September 28th 2024

Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes

Gupta N, Patel HD, Taylor J, Borin JF, Jacobsohn K, Kenfield SA, Eggener SE, Price C, Davuluri M, Byrne N, Bivalacqua TJ, Loeb S. “Systematic review of the impact of a plant-based diet on prostate cancer incidence and outcomes” Prostate Cancer Prostatic Dis. 2022 Jul 5. PMID: 35790788. Link: https://pubmed.ncbi.nlm.nih.gov/35790788/   This is a systematic… Read More


Comment
Saturday, September 28th 2024

Association of Plant-Based Diet Index with Prostate Cancer Risk

Loeb S, Fu BC, Bauer SR, Pernar CH, Chan JM, Van Blarigan EL, Giovannucci EL, Kenfield SA, Mucci LA “Association of Plant-Based Diet Index with Prostate Cancer Risk” American Journal of Clinical Nutrition. 2021 Nov 13:nqab365. PMID: 34791008. Link: https://pubmed.ncbi.nlm.nih.gov/34791008/   This study examined the relationship between consumption of plant-based food and risk of prostate… Read More


Comment
Wednesday, September 25th 2024

Plant-Based Diet Associated with Better Quality of Life in Prostate Cancer Survivors

UroToday: Plant-Based Diet Associated with Better Quality of Life in Prostate Cancer Survivors (March 12, 2024) Link: https://www.urotoday.com/video-lectures/prostate-cancer/video/3941-plant-based-diet-associated-with-better-quality-of-life-in-prostate-cancer-survivors-stacy-loeb.html


Comment
Wednesday, September 25th 2024

Our Food Choices: The Impact on Health, Environment & Social Justice

NYU Langone Health. Our Food Choices: The Impact on Health, Environment & Social Justice (published January 8, 2024) 


Comment
Wednesday, September 25th 2024

Sexual Function After Prostate Cancer Treatment

Urology Care Foundation Podcast: Sexual Function After Prostate Cancer Treatment (September 28, 2023) 


Comment
Wednesday, September 25th 2024

Eat your Greens – Exploring How Plant-based Diets can Impact Men’s Health Issues

Man Up Podcast: Eat your Greens – Exploring How Plant-based Diets can Impact Men’s Health Issues (January 6, 2023) 


Comment
Wednesday, September 25th 2024

Plant Based Diet Benefits for Health, the Environment and Social Justice

NYU Langone Health. Plant Based Diet Benefits for Health, the Environment and Social Justice (published January 25, 2023) 


Comment
Wednesday, September 25th 2024

Shared Decision-Making for Prostate Cancer

Us TOO Prostate Cancer Support & Education Network: Shared Decision-Making for Prostate Cancer (April 22, 2021) 


Comment
Wednesday, September 25th 2024

Black Men’s Prostate Cancer Initiative Webinar Series: Eating for Prostate Health, Sexual Health & Heart Health

Us TOO Prostate Cancer Support & Education Network. Black Men’s Prostate Cancer Initiative Webinar Series: Eating for Prostate Health, Sexual Health & Heart Health (March 25, 2021) 


Comment
Wednesday, September 25th 2024

IMPLEMENT Study: Addressing the Underutilization of Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer

UroToday. IMPLEMENT Study: Addressing the Underutilization of Treatment Intensification in Metastatic Castration-Sensitive Prostate Cancer (June 18, 2024) Link: https://www.urotoday.com/video-lectures/advanced-prostate-cancer/video/4138-implement-study-addressing-the-underutilization-of-treatment-intensification-in-metastatic-castration-sensitive-prostate-cancer-stacy-loeb.html


Comment
Wednesday, September 25th 2024

Episode 5: Stacy Loeb and Genetic Tumor Board

Prostate Cancer Prostatic Diseases Podcast Episode 5: Stacy Loeb and Genetic Tumor Board (March 30, 2024) 


Comment